Webinar | February 5, 2021

Assess Pyrogenic Risk In Pharmaceutical Process With The Monocyte Activation Test

Microbial risk in pharmaceutical process cannot be limited to viable microorganisms. Learn how the MAT can help you to assess the pyrogenic risk resulting from your production process.

The monocyte activation test (MAT) provides an in vitro alternative to conventional animal testing methods in accordance with regulatory guidelines.

Speakers: Mathilde Arnault, Research Scientist, Merck KGaA, Darmstadt, Germany

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: